1. Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.
- Author
-
Moghimi, Setareh, Salarinejad, Somayeh, Toolabi, Mahsa, Firoozpour, Loghman, Esmaeil Sadat Ebrahimi, Seyed, Safari, Fatemeh, Madani-Qamsari, Fatemeh, Mojtabavi, Somayeh, Faramarzi, Mohammad Ali, Karima, Saeed, Pakrad, Roya, and Foroumadi, Alireza
- Subjects
- *
MOLECULAR docking , *HYBRID systems , *HYDROGEN bonding interactions , *TRIAZOLE derivatives , *PYRIDAZINES - Abstract
[Display omitted] • A series of pyridazine-triazole based compounds were synthesized as α-glucosidase inhibitors. • The most active compound was nearly 10 times more active than acarbose. • Kinetic, molecular docking and cytotoxic studies were also performed. In this study, we reported the discovery of pyridazine based 1,2,3-triazole derivatives as inhibitors of α-glucosidase. All target compounds exhibited significant inhibitory activities against yeast and rat α-glucosidase enzymes compared to positive control, acarbose. The most potent compound 6j , ethyl 3-(2-(1-(4-nitrobenzyl)-1 H -1,2,3-triazol-4-yl)ethyl)-5,6-diphenylpyridazine-4-carboxylate exhibited IC 50 values of 58, and 73 µM. Docking studies indicated the responsibility of hydrophobic and hydrogen bonding interactions in the ligand-enzyme complex stability. The in-vitro safety against the normal cell line was observed by toxicity evaluation of the selected compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF